早期肺癌之原位癌AIS

2021-05-27 叶波 网络

原位癌(Adenocarcinoma in situ, AIS),是从正常组织转化为肿瘤细胞发展的第一个阶段。它的特性和影像特征,处理原则与浸润性癌有显著区别。

原位癌(Adenocarcinoma in situ, AIS),是从正常组织转化为肿瘤细胞发展的第一个阶段。是指粘膜上皮细胞层内的非典型增生至癌变,基底层完整,细胞尚未突破基底膜。它是肿瘤的早期甚至是早早期阶段,这种病变有向癌转变的趋势,继续发展,会突破上皮基底层,变成微浸润性癌(minimally invasive adenocarcinoma, MIA),甚至变为浸润性癌(invasive adenocarcinoma cancer, IAC)。因此,原位癌AIS,微浸润性癌MIA,浸润性癌IAC是疾病发展的不同阶段。

原位癌AIS的主要特性如下:

 

  1. 生长极为缓慢,大部分保持稳定10年以上。

  2. 不突破基底膜,意味着肿瘤局限于上皮层内,没有血管和淋巴管进入,因此不会发生远处和淋巴结转移。

  3. 切除后不会复发,不影响生存期。

     

以下均为近年来经我手术确诊的原位癌患者术前影像:

影像特征:多为<1cm的毛玻璃影,密度较低,可有毛刺、空泡,血管通过等高危特征,一般即使有血管通过,也无血管弯曲,也可无明显高危特征,但在随访过程中无明显变化。


AIS的处理原则:由于原位癌生长缓慢,不会转移,此阶段对于身体没有危险性,2021年WHO已将原位癌剔除肺癌范畴,跟不典型增生一起,被认为是癌前病变,因此可以不手术切除,一般根据结节大小,建议6-12个月复查胸部CT随访。随访过程中,如发现结节变大,或密度增加等,提示有生长性,则再手术也来得及。如果患者心理压力比较大,或者结节>8mm,有较多高危特征,也可直接胸腔镜手术切除。需要注意的是,原位癌AIS切除后即治愈,不会复发,不需要术后辅助治疗。可以说,切除后就是正常人。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1634947, encodeId=cd9d163494ea3, content=<a href='/topic/show?id=f8072189cf' target=_blank style='color:#2F92EE;'>#AIS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2189, encryptionId=f8072189cf, topicName=AIS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ef022348744, createdName=膀胱癌, createdTime=Thu Jun 24 20:04:41 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744905, encodeId=f0b41e449051a, content=<a href='/topic/show?id=af1b3e01076' target=_blank style='color:#2F92EE;'>#原位癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37010, encryptionId=af1b3e01076, topicName=原位癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5435458088, createdName=july_987, createdTime=Sat Nov 27 21:04:41 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666182, encodeId=5c87166618243, content=<a href='/topic/show?id=5fd55943ecf' target=_blank style='color:#2F92EE;'>#早期肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59437, encryptionId=5fd55943ecf, topicName=早期肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=592126038749, createdName=循证小兵, createdTime=Sun Dec 05 03:04:41 CST 2021, time=2021-12-05, status=1, ipAttribution=)]
    2021-06-24 膀胱癌
  2. [GetPortalCommentsPageByObjectIdResponse(id=1634947, encodeId=cd9d163494ea3, content=<a href='/topic/show?id=f8072189cf' target=_blank style='color:#2F92EE;'>#AIS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2189, encryptionId=f8072189cf, topicName=AIS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ef022348744, createdName=膀胱癌, createdTime=Thu Jun 24 20:04:41 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744905, encodeId=f0b41e449051a, content=<a href='/topic/show?id=af1b3e01076' target=_blank style='color:#2F92EE;'>#原位癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37010, encryptionId=af1b3e01076, topicName=原位癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5435458088, createdName=july_987, createdTime=Sat Nov 27 21:04:41 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666182, encodeId=5c87166618243, content=<a href='/topic/show?id=5fd55943ecf' target=_blank style='color:#2F92EE;'>#早期肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59437, encryptionId=5fd55943ecf, topicName=早期肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=592126038749, createdName=循证小兵, createdTime=Sun Dec 05 03:04:41 CST 2021, time=2021-12-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1634947, encodeId=cd9d163494ea3, content=<a href='/topic/show?id=f8072189cf' target=_blank style='color:#2F92EE;'>#AIS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2189, encryptionId=f8072189cf, topicName=AIS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ef022348744, createdName=膀胱癌, createdTime=Thu Jun 24 20:04:41 CST 2021, time=2021-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744905, encodeId=f0b41e449051a, content=<a href='/topic/show?id=af1b3e01076' target=_blank style='color:#2F92EE;'>#原位癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37010, encryptionId=af1b3e01076, topicName=原位癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b5435458088, createdName=july_987, createdTime=Sat Nov 27 21:04:41 CST 2021, time=2021-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1666182, encodeId=5c87166618243, content=<a href='/topic/show?id=5fd55943ecf' target=_blank style='color:#2F92EE;'>#早期肺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59437, encryptionId=5fd55943ecf, topicName=早期肺癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=592126038749, createdName=循证小兵, createdTime=Sun Dec 05 03:04:41 CST 2021, time=2021-12-05, status=1, ipAttribution=)]